Actas Dermo-Sifiliográficas

Reply to Martorell Calatayud et al., “Cost-Consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-Severe Hidradenitis Suppurativa” J. Romaní;

Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging A. Martorell; F. Alfageme Roldán; F.J. García-Martínez; A. Molina Leyva; J.C. Pascual Ramírez; E. Vilarrasa;

Cost-consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-severe Hidradenitis Suppurativa A. Martorell; A. Molina-Leyva; A. Jiménez Morales; C. Blanch;